Retour
Prix Unicycive Therapeutics Inc (UNCY)
Graphique du cours de l'action UNCY
UNCY Dividendes
Unicycive Therapeutics Inc
$6.19
-1.27%
$-0.07
À la fermeture : Jan 16, 16:00:00 GMT-5
$6.22
0.48%
$0.02
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$6.27
Prix d'ouverture
$6.27
Plage de la journée
$6.01 - $6.3
Plage de 52 semaines
$3.71 - $11
Volume
582.3K
Volume moyen
436.7K
BPA (TTM)
-2.01
Rendement en dividend
--
Capitalisation boursière
$133.6M
Qu’est-ce que UNCY ?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
